Soft Tissue Lesion clinical trials at UCSF
1 in progress, 0 open to eligible people
Showing trials for
PET [89Zr]DFO-starPEG in Solid Tumors
Sorry, not yet accepting patients
This is a first-in-human, pilot study of the novel PET-imaging radiotracer [89Zr]DFO-starPEG. The study is designed to obtain preliminary data to support future development of this agent as an imaging surrogate to visualize enhanced permeability and retention (EPR)-mediated tracer uptake before administration of EPR-based nanomedicines.
San Francisco, California
Our lead scientists for Soft Tissue Lesion research studies include Robert Flavell, MD, PhD.
Last updated: